Deutsche Bank’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Deutsche Bank’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-643	Closed	-$11K	–	4774
2021 Q2	$11K	Sell	643 -2,858	-82%	-$54.2K	﹤0.01%	4462
2021 Q1	$92K	Sell	3,501 -311	-8%	-$14.1K	﹤0.01%	4022
2020 Q4	$137K	Buy	3,812 +1,087	+40%	+$39.3K	﹤0.01%	3673
2020 Q3	$97K	Buy	2,725 +1,124	+70%	+$48.9K	﹤0.01%	3563
2020 Q2	$68K	Buy	1,601 +1,287	+410%	+$86.7K	﹤0.01%	3654
2020 Q1	$25K	Sell	314 -144	-31%	-$11.5K	﹤0.01%	3856
2019 Q4	$40K	Buy	458 +189	+70%	+$15.9K	﹤0.01%	4066
2019 Q3	$18K	Sell	269 -441	-62%	-$33.9K	﹤0.01%	4367
2019 Q2	$69K	Buy	+710	New	+$55K	﹤0.01%	4377
2018 Q1	–	Sell	-2,971	Closed	-$521K	–	5688
2017 Q4	$521K	Buy	+2,971	New	+$336K	﹤0.01%	3577
2017 Q3	–	Sell	-490	Closed	-$23K	–	5179
2017 Q2	$23K	Buy	490 +414	+545%	+$72.5K	﹤0.01%	4542
2017 Q1	$10K	Buy	+76	New	+$9.86K	﹤0.01%	4624
2015 Q3	–	Sell	-4	Closed	-$3K	–	5411
2015 Q2	$3K	Buy	+4	New	+$2.57K	﹤0.01%	5205
2015 Q1	–	Sell	-196	Closed	-$131K	–	6160
2014 Q4	$131K	Buy	+196	New	+$148K	﹤0.01%	4547

Other funds holding EVFM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Deutsche Bank's EVFM Position: Q3 2021 in Review

Deutsche Bank sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q3 2021, closing a stake of 643 shares — an estimated $11K sold.

Deutsche Bank first reported a position in EVFM in Q4 2014 and held it in 14 quarters. The position peaked at $521K in Q4 2017. 71 funds tracked by Wall St. Rank hold EVFM as of Q3 2021.

Deutsche Bank reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Deutsche Bank sold 643 Evofem Biosciences, Inc. Common Stock shares in Q3 2021, an estimated $11K.
Deutsche Bank first reported a position in Evofem Biosciences, Inc. Common Stock in Q4 2014 and held it in 14 quarters.
Deutsche Bank's Evofem Biosciences, Inc. Common Stock position peaked at $521K in Q4 2017.
71 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.